[1]EuropeanJournalofMedicinalChemistry,2019,vol.174,p.236-251
19995-46-1
20699-86-9
98589-46-9
6345-55-7
34084-88-3
200400-76-6 | Ethyl 2-(4'-hydroxyphenyl)-1,3-oxazole-4-carboxylate | AA002CNO | MFCD02183587
20099-90-5 | 4-(2-Bromoacetyl)benzoic acid | AA002D1C | MFCD00229872
201418-83-9 | Boc-hci-oh | AA002DBQ | MFCD00151903
18951-85-4 | (R)-(+)-Citronellic acid | AA002DNM | MFCD00075195
19005-93-7 | 1H-Indole-2-carbaldehyde | AA002E7G | MFCD03001425
19065-49-7 | 1-Methylazepan-4-ol | AA002EN8 | MFCD00190597
1910-90-3 | 6-Bromo-1,4-dihydroquinoxaline-2,3-dione | AA002EXL | MFCD09842525
19158-90-8 | (3,4-Dihydro-1h-isochromen-1-ylmethyl)amine | AA002F9O | MFCD00457645
192189-18-7 | 1-Boc-3-iodo-7-azaindole | AA002FN5 | MFCD08741526
192564-14-0 | Oritavancin diphosphate | AA002G0Y | MFCD29472248